Xiamen Aide Biological Pharmaceutical Technology Co., Ltd. Announcement on the Proposed Reappointment of Accounting Firm
The company and all members of the board of directors guarantee that the content of the information disclosure is true, accurate, and complete, without false records, misleading statements, or major omissions.
Special Reminder: This reappointment complies with the provisions of the "Management Measures for the Selection of Accounting Firms by State-owned Enterprises and Listed Companies" issued by the Ministry of Finance, the State-owned Assets Supervision and Administration Commission of the State Council, and the China Securities Regulatory Commission (Cai Kuai [2023] No. 4).